SSR Mining enters the first week of June with a notable split developing: a bellwether analyst just turned constructive on the stock while short sellers have been quietly building positions for more than a month. That tension — fresh institutional validation against a rising short base — is the defining feature of this week's setup.
RBC Capital upgraded SSRM to Outperform today, June 3, though the bank simultaneously trimmed its price target to CAD $40. That combination — a ratings lift paired with a target cut — captures the Street's prevailing mood on the name: renewed confidence in the investment case, but measured expectations heading into Q2. Scotiabank's commentary, meanwhile, carries a bearish slant on FY2027 earnings, making the RBC move feel less like a broad bullish turn and more like one house stepping off the sidelines while others remain cautious. The stock also just announced an LOI with Phenom Resources for a joint venture covering a 15% interest in the Dobbin project, adding a modest corporate development angle to a week already charged with analyst activity.
On the positioning side, the short story is worth noting — not because the absolute level is alarming, but because the direction of travel has been persistent. Short interest has risen 30% over the past month and 15% over the past week alone, reaching roughly 0.68% of the free float. The raw percentage is modest — this is not a heavily shorted stock by any measure. But the pace of accumulation is unusual for a name where borrowing costs are falling, not rising. Cost to borrow has declined more than 20% over the past week to approximately 0.43%, and availability is extraordinarily loose at over 3,200% — meaning the lending pool is nowhere near exhausted. The rising shorts are a deliberate directional bet, not a squeeze play. With official data through May 15 pegging days-to-cover at 2.3, there is no immediate borrow pressure on the horizon.
The stock itself has had a softer week, slipping 3.3% to CAD $41.27 against a gold-sector backdrop that was mixed to slightly better. Close peers IMG and WPM each posted gains of around 1% on the day, while ARIS and AGI fell. The underperformance is not dramatic, but it does stand out given SSRM's strong run over the past month — up 4.1% — and its more meaningful year-to-date outperformance versus the peer group.
The institutional picture provides some grounding. FMR added over 3.1 million shares in the most recent reporting period, and Millennium Management built a new position of more than 2.2 million shares through Q1. BlackRock, already the largest holder at roughly 9.2% of shares, added another 725,000. That accumulation pattern — active managers and index giants both adding — points to a broader vote of confidence in the recovery thesis. Insider activity from early April showed a cluster of executive sells following equity awards on April 1, all at prices around CAD $31.62, well below where the stock trades today. The awards were larger than the sales across most executives, and the net 90-day insider position is positive — roughly $9 million net bought across 441,000 shares.
The next earnings event is scheduled for July 31. After the most recent Q1 print in May, the stock moved roughly 5% higher on the day and held those gains through the following week — a constructive reaction pattern that will frame how investors approach the Q2 report. With the RBC upgrade now on the tape, the short base growing quietly in the background, and a joint venture announcement adding a small catalyst, the stock's July print becomes the next major test of whether the fundamental momentum — 75% year-over-year sales growth and an improving F-score of 8 — continues to outpace the sceptics now accumulating short positions.
See the live data behind this article on ORTEX.
Open SSRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
